Healthcare -
Biotechnology - NASDAQ - US
$ 8.32
2.4 %
$ 316 M
Market Cap
14.0
P/E
TRDA - TOTAL CURRENT ASSETS
Total Current Assets TRDA - Entrada Therapeutics, Inc.
440 M
LAST VALUE
44.80%
2 YEAR CAGR
90.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR